Table 1.
Baseline Characteristics of LTx Recipients and Comparison According to Serological Response
| Characteristics | Entire (n=35) | Seronegative (n=29) | Seropositive (n=6) | P value | Missing |
|---|---|---|---|---|---|
| Age, years | 47 (40–53) | 47 (41–53) | 47 (31–55) | 0.685 | 0 |
| Male sex | 30 (85.7) | 26 (89.6) | 4 (66.7) | 0.143 | 0 |
| BMI, kg/m2 | 23.8 (20.8–25.6) | 23.9 (21.9–25.7) | 20.4 (18.9–24.4) | 0.124 | 0 |
| Time since LT | 2.4 (2.0–5.5) | 2.3 (1.9–4.0) | 6.3 (2.3–8.6) | 0.025 | 0 |
| IL-2R Induction | 31 (88.5%) | 28 (96.5%) | 3 (50%) | 0.011 | 0 |
| Immunosuppressant | 0.897 | 0 | |||
| Tacrolimus | 28 | 23 | 5 | 0 | |
| Cyclosporin | 1 | 1 | 0 | 0 | |
| Sirolimus | 6 | 5 | 1 | 0 | |
| MPA | 15 (42.8%) | 15 (52.7%) | 0 (0%) | 0.027 | 0 |
Abbreviations: LTx, liver transplant; BMI, body mass index; IL-2R, interleukin-2 receptor; MPA, derivatives from mycophenolic acid.